SMAD2 and Hyperglycemia: We demonstrate for the first time that metformin prevents hyperglycaemia-induced increase in DDR2 expression in vascular adventitial fibroblasts by inhibiting the TGF-β1/SMAD2/3 signalling pathway, which enhances DDR2 expression in response to hyperglycaemia.